Key Announcement
Lupin Limited announced that it has been recognized among India's Best Employers in the Nation-Builders Category 2026 by Great Place To Work® India. The company ranked among the Top 14 organizations nationally in this category.
Recognition Details
The Nation-Builders category recognizes organizations whose impact extends beyond business performance through their contribution to:
- Employment generation
- People development
- Community advancement
- Nation-building
- Fostering exceptional workplace cultures
Evaluation Criteria
The selection was based on a rigorous, independent assessment conducted by Great Place To Work® India, including:
- Trust Index™ measuring employee experience
- Culture Audit™ evaluations of people practices
- Eligibility criteria assessing organization's broader contribution to nation-building
Management Commentary
Yashwant Mahadik, President – Global Human Resources, Lupin, stated: "We are honored by this recognition, which celebrates the culture our people bring to life every day. At Lupin, we are focused on creating an environment where individuals feel supported, empowered, and connected to a shared purpose. By investing in our people and their growth, we are building a workplace that enables meaningful contributions to patients, communities, and society."
Company Background
Lupin Limited is a global pharmaceutical leader headquartered in Mumbai, India, with products distributed in over 100 markets. The company specializes in:
- Branded and generic formulations
- Complex generics
- Biotechnology products
- Active pharmaceutical ingredients
Operational Scale
The company maintains:
- 15 state-of-the-art manufacturing sites globally
- 7 research centers globally
- Over 26,000 professionals in workforce
Therapy Areas
Lupin has a strong position in India and the U.S. across multiple therapy areas including:
- Respiratory
- Cardiovascular
- Anti-diabetic
- Anti-infective
- Gastrointestinal
- Central nervous system
- Women's health
Subsidiaries
The company operates through subsidiaries including:
- Lupin Diagnostics
- Lupin Digital Health
- Lupin Manufacturing Solutions
Financial Impact
Financial impact not quantified in the disclosure. The recognition represents a non-financial achievement related to workplace culture and employer branding.